Australia Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Nicotine Replacement Therapy, E-Cigarettes), By Distribution Channel (Online, Offline), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                  1.1. Market Segmentation
                  1.2. Market Definitions
                  1.3. Objectives
                      1.3.1 Objective - 1
                      1.3.2 Objective - 2
                      1.3.3 Objective - 3
                  1.4. Research Methodology
                      1.4.1 Information Procurement
                      1.4.2 Purchased Database
                      1.4.3 GVR’s Internal Database
                      1.4.4 Secondary Sources
                      1.4.5. Primary Research
                  1.5 Information Or Data Analysis
                      1.5.1. Data Analysis Models
                  1.6 Market Formulation & Validation
                  1.7 Model Details
                  1.8 Commodity Flow Analysis
                      1.8.1 List Of Secondary Sources
                      1.8.2 List Of Abbreviations
                      1.8.3 List Of Primary Sources
Chapter 2 Executive Summary
                  2.1 Market And Product Segment Snapshot
                  2.2 Distribution Channel Segment Snapshot
                  2.3 Competitive Landscape Snapshot
Chapter 3 Australia Nicotine Replacement Therapy Market Variables, Trends, And Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market
                  3.2 Market Dynamics
                      3.2.1 Market Driver Analysis
                          3.2.1.1 Technological Advancements
                          3.2.1.2 Rise In Awareness About Ill Effects Of Smoking
                          3.2.1.3 Rising Number Of People Undergoing Smoking Cessation
                      3.2.2 Market Restraint Analysis
                          3.2.2.1 Stringent Regulatory Framework
                  3.3 Regulatory Scenario
                  3.4 Epidemiology Analysis
                  3.5 Business Environment Analysis
                      3.5.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
                      3.5.2 Industry Analysis - Porter’s
Chapter 4 Australia Nicotine Replacement Therapy Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)
                  4.1 Australia Nicotine Replacement Therapy Market: Product Movement Analysis
                  4.2 Australia Nicotine Replacement Therapy Market Estimates & Forecast, By Product (USD Million)
                      4.2.1 Nicotine Replacement Therapy
                          4.2.1.1 Inhalers
                          4.2.1.2 Gum
                          4.2.1.3 Transdermal Patches
                          4.2.1.4 Sublingual Tablets
                          4.2.1.5 Lozenges
                          4.2.1.6 Others
                      4.2.2 E-cigarettes
                      4.2.3 Heat-not-burn Tobacco Products
Chapter 5 Australia Nicotine Replacement Therapy Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
                  5.1 Australia Nicotine Replacement Therapy Market: Distribution Channel Movement Analysis
                  5.2 Australia Nicotine Replacement Therapy Market Estimates & Forecast, By Distribution Channel (USD Million)
                      5.2.1 Online
                      5.2.2 Offline
                          5.2.2.1 Hospital Pharmacies
                          5.2.2.2 Retail Pharmacies
                          5.2.2.3 Others (Supermarkets & Other Modes)
Chapter 6 Australia Nicotine Replacement Therapy Market - Competitive Landscape
                  6.1 Participant’s Overview
                  6.2 Financial Performance
                  6.3 Participant Categorization
                      6.3.1 Market Leaders
                      6.3.2 Market Share Analysis, 2023
                      6.3.3 Company Profiles
                          6.3.3.1 Philip Morris Products S.A. (Altria Group)
                              6.3.3.1.1 Company Overview
                              6.3.3.1.2 Financial Performance
                              6.3.3.1.3 Product Benchmarking
                              6.3.3.1.4 Strategic Initiatives
                          6.3.3.2 British American Tobacco P.L.C.
                              6.3.3.2.1 Company Overview
                              6.3.3.2.2 Financial Performance
                              6.3.3.2.3 Product Benchmarking
                              6.3.3.2.4 Strategic Initiatives
                          6.3.3.3 Haleon Group Of Companies
                              6.3.3.3.1 Company Overview
                              6.3.3.3.2 Financial Performance
                              6.3.3.3.3 Product Benchmarking
                              6.3.3.3.4 Strategic Initiatives
                          6.3.3.4 Johnson & Johnson Services, Inc.
                              6.3.3.4.1 Company Overview
                              6.3.3.4.2 Financial Performance
                              6.3.3.4.3 Product Benchmarking
                              6.3.3.4.4 Strategic Initiatives
                          6.3.3.5 Liber Pharmaceuticals Pty Ltd
                              6.3.3.5.1 Company Overview
                              6.3.3.5.2 Financial Performance
                              6.3.3.5.3 Product Benchmarking
                              6.3.3.5.4 Strategic Initiatives
                          6.3.3.6 Philip Morris Products S.A. (Altria Group)
                              6.3.3.6.1 Company Overview
                              6.3.3.6.2 Financial Performance
                              6.3.3.6.3 Product Benchmarking
                              6.3.3.6.4 Strategic Initiatives
                          6.3.3.7 Alphapharm Pty Limited
                              6.3.3.7.1 Company Overview
                              6.3.3.7.2 Financial Performance
                              6.3.3.7.3 Product Benchmarking
                              6.3.3.7.4 Strategic Initiatives
                          6.3.3.8 Perrigo Company Plc
                              6.3.3.8.1 Company Overview
                              6.3.3.8.2 Financial Performance
                              6.3.3.8.3 Product Benchmarking
                              6.3.3.8.4 Strategic Initiatives
                          6.3.3.9 Amcal
                              6.3.3.9.1 Company Overview
                              6.3.3.9.2 Financial Performance
                              6.3.3.9.3 Product Benchmarking
                              6.3.3.9.4 Strategic Initiatives
                          6.3.3.10 GAK Plc
                              6.3.3.10.1 Company Overview
                              6.3.3.10.2 Financial Performance
                              6.3.3.10.3 Product Benchmarking
                              6.3.3.10.4 Strategic Initiatives
Chapter 7 Conclusion

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Australia nicotine replacement therapy market revenue estimates and forecasts, by product, 2018 - 2030 (USD Million)
Table 4 Australia nicotine replacement therapy market revenue estimates and forecasts, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Australia Nicotine Replacement Therapy Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market and product segment snapshot
Fig. 10 Distribution channel segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Status of daily smokers - Australia (1991 - 2023)
Fig. 14 Trend in incidence of lung cancer (2000 - 2023)
Fig. 15 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 16 Industry analysis - Porter’s
Fig. 17 Australia nicotine replacement therapy market: Product outlook and key takeaways
Fig. 18 Australia nicotine replacement therapy market: Product movement analysis
Fig. 19 Nicotine replacement therapy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Inhalers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Gum market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Transdermal patches market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Sublingual tablets market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Lozenges market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 E-cigarettes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Australia nicotine replacement therapy market: Distribution channel outlook and key takeaways
Fig. 28 Australia nicotine replacement therapy market: Distribution channel movement analysis
Fig. 29 Online market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Offline market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Others (supermarkets & other modes) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Market participant categorization
Fig. 35 Australia nicotine replacement therapy market share analysis, 2022